Cargando…

The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor

Cylindromas are benign adnexal skin tumors caused by germline mutations in the CYLD gene. In most cases the second wild-type allele is lost in tumor tissue, suggesting that CYLD functions as tumor suppressor. CYLD is a protein of 956 amino acids harboring a functional deubiquitinating domain at the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regamey, Alexandre, Hohl, Daniel, Liu, Jia Wei, Roger, Thierry, Kogerman, Priit, Toftgård, Rune, Huber, Marcel
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2003
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194148/ https://www.ncbi.nlm.nih.gov/pubmed/14676304 http://dx.doi.org/10.1084/jem.20031187

Ejemplares similares

Stimulus-dependent Synergism of the Antiapoptotic Tumor Necrosis Factor Receptor–associated Factor 2 (TRAF2) and Nuclear Factor κB Pathways
por: Lee, Soo Young, et al.
Publicado: (1998)

The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)
por: Muzio, Marta, et al.
Publicado: (1998)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
por: Masoumi, K. C., et al.
Publicado: (2011)

Essential Role of Nuclear Factor (NF)-κB–Inducing Kinase and Inhibitor of κb (Iκb) Kinase α in Nf-κb Activation through Lymphotoxin β Receptor, but Not through Tumor Necrosis Factor Receptor I
por: Matsushima, Akemi, et al.
Publicado: (2001)

Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis
por: Stehlik, Christian, et al.
Publicado: (1998)

Potential role for the tumor suppressor CYLD in brain and notochord development
por: Li, Te, et al.
Publicado: (2021)

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
por: Bekas, Nikolaos, et al.
Publicado: (2023)

APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth
por: Hahne, Michael, et al.
Publicado: (1998)

Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor
por: Takahashi, Nozomi, et al.
Publicado: (1999)

A Mediator Role For Metallothionein in Tumor Necrosis Factor–induced Lethal Shock
por: Waelput, Wim, et al.
Publicado: (2001)

Type I interferon drives tumor necrosis factor–induced lethal shock
por: Huys, Liesbeth, et al.
Publicado: (2009)

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
por: Hövelmeyer, Nadine, et al.
Publicado: (2007)

Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction
por: Schwandner, Ralf, et al.
Publicado: (2000)

Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis
por: Frei, Karl, et al.
Publicado: (1997)

Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors
por: Pronk, Cornelis J.H., et al.
Publicado: (2011)

Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors
por: Ruby, Janet, et al.
Publicado: (1997)

Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting
por: Körner, Heinrich, et al.
Publicado: (1997)

A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member April, Inhibits Tumor Cell Growth
por: Rennert, Paul, et al.
Publicado: (2000)

Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria
por: Engwerda, Christian R., et al.
Publicado: (2002)

Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population
por: Thompson, Jeffrey S., et al.
Publicado: (2000)

Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6
por: Häcker, Hans, et al.
Publicado: (2000)

Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen
por: Schneider, Pascal, et al.
Publicado: (2001)

Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α
por: Boyman, Onur, et al.
Publicado: (2004)

Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Suenaga, Naoki, et al.
Publicado: (2019)

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells
por: Notley, Clare A., et al.
Publicado: (2008)

Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation
por: Xia, Xing-Zhong, et al.
Publicado: (2000)

Prostaglandin E2 and Tumor Necrosis Factor α Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production
por: Rieser, Claudia, et al.
Publicado: (1997)

TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
por: Wong, Brian R., et al.
Publicado: (1997)

CASPASE 8 inhibits programmed necrosis by processing CYLD
por: O’Donnell, Marie Anne, et al.
Publicado: (2011)

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma
por: Steininger, Anne, et al.
Publicado: (2011)

The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer
por: Chen, Yangming, et al.
Publicado: (2020)

“Re-educating” tumor-associated macrophages by targeting NF-κB
por: Hagemann, Thorsten, et al.
Publicado: (2008)

Tracking tumor kinetics in patients with germline CYLD mutations
por: Brown, Sarah, et al.
Publicado: (2018)

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4(+)T Cells in HIV-1–Infected Hu-Pbl-Nod-Scid Mice
por: Miura, Yoshiharu, et al.
Publicado: (2001)

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020)

The tumour suppressor CYLD regulates the p53 DNA damage response
por: Fernández-Majada, Vanesa, et al.
Publicado: (2016)

Protein Kinase C β Controls Nuclear Factor κB Activation in B Cells Through Selective Regulation of the IκB Kinase α
por: Saijo, Kaoru, et al.
Publicado: (2002)

Nonsense‐mediated decay factor SMG7 sensitizes cells to TNFα‐induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1
por: Yang, Limeng, et al.
Publicado: (2020)

Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population
por: Ørsted, David Dynnes, et al.
Publicado: (2007)

Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
por: Ingram, David A., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_9b31hl73t5rha3egr3o7rg6eek